The International Conference on Malignant Lymphoma (ICML) has become, since the first edition in 1981, a must-attend event for the scientific community involved in the study and treatment of lymphoid neoplasms. ICML is presented every two years to allow the presentation and discussion of the most recent basic and clinical data by nearly 3,000 haematologists, clinical oncologists, radio-oncologists, pediatricians, pathologists, and leading researchers. Some of the general sessions are not focused on a specific morphologic subtype, but rather on pathways or other biological aspects in order to allow for the presentation of basic and clinical data in the same session.